loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r0_cep_2000_304___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Contipro Pharma a.s

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Contipro Cas Usti Nad Orlici CZ (1)

    filter

    01 Sodium hyaluronate, Intrinsic viscosity: more than 2.5 m3/kg, by fermentation, for parenteral administration including intra-ocular administration and for intra-ocular use (1)

    filter

    01 Czech Republic (1)

    filter

    01 Expired (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Contipro Cas Usti Nad Orlici CZ

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Czech Republic
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Sodium hyaluronate, Intrinsic viscosity: more than 2.5 ...

      PDF Supplier PDF
      URL Supplier Web Content
      R0-CEP 2000-304 - Rev 01
      Expired
      Chemical
      2004-10-22
      2008-03-10
      1472
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R0-CEP 2000-304 - Rev 01 of Contipro Cas Usti Nad Orlici Cz

      Looking for Certificates of Suitability (CEPs) for R0-CEP 2000-304 - Rev 01 of Contipro Cas Usti Nad Orlici Cz 1

      20

      Contipro Cas Usti Nad Orlici Cz, based in Czech Republic, is a pharmaceutical company.

      One of their significant offerings is Sodium hyaluronate, Intrinsic viscosity: more than 2.5 m3/kg, by fermentation, for parenteral administration including intra-ocular administration and for intra-ocular use, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2000-304 - Rev 01

      This Chemical Type CEP, issued on October 22, 2004, remains in force until March 10, 2008, ensuring its reliability within the pharmaceutical industry.

      Substance Number 1472 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY